Influence of Anti-Tumor Necrosis Factor Therapy on Cancer Incidence in Patients With Rheumatoid Arthritis Who Have Had a Prior Malignancy: Results From the British Society for Rheumatology Biologics Register

Arthritis Care and Research - United States
doi 10.1002/acr.20129
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Wiley

Related search

Biologic Refractory Disease in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2018English

Venous Thrombotic Events Are Not Increased in Patients With Rheumatoid Arthritis Treated With Anti-TNF Therapy: Results From the British Society for Rheumatology Biologics Register

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

Examining Changes in Central and Peripheral Pain as Mediates of Fatigue Improvement: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2016English

Safety of Tumor Necrosis Factor Inhibitor Therapy in Patients With a Prior Malignancy

International Journal of Rheumatic Diseases
Rheumatology
2016English

Anti-TNF Therapies and Pregnancy: Outcome of 130 Pregnancies in the British Society for Rheumatology Biologics Register

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

Malignancy Risk in Australian Rheumatoid Arthritis Patients Treated With Anti-Tumour Necrosis Factor Therapy: Analysis of the Australian Rheumatology Association Database (ARAD) Prospective Cohort Study

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2015English

PMS73 Visualizing Treatment Patterns of Veteran Patients With Rheumatoid Arthritis Who Initiated Tumor Necrosis Factor Therapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis

Reumatologia
RheumatologyAllergyImmunology
2012English

PMS9 Biologic Therapy Patterns and Associated Costs in Rheumatoid Arthritis Patients Who Initiated a Tumor Necrosis Factor Antagonist Over Two Years

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy